Imidazoline and α(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy

Biological Psychiatry

Volumn 48, Issue 9, 2000, Pages 932-939

  Piletz, John E ^a,b   Halbreich, Uriel ^c,d  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

2 adrenoceptors; Depression; Estrogen; Imidazoline receptors; Luteinizing hormone; Menopause; Monoamine oxidase

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CLONIDINE; ESTRADIOL; IMIDAZOLINE RECEPTOR;

ADULT; ARTICLE; BINDING SITE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ESTROGEN THERAPY; FEMALE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MOOD; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; THROMBOCYTE;

ADULT; AFFINITY LABELS; BINDING SITES; BLOOD PLATELETS; CLONIDINE; DEPRESSIVE DISORDER; DOWN-REGULATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG;

EID: 0034333139     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00849-0     Document Type: Article

References (66)

1. Clonidine reverses spatial learning deficits and reinstates 0 frequencies in rats with spatial fornix section
2. 2-adrenergic receptor activity
3. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects
4. Plasma neurotransmitter profile during different phases of the ovulatory cycle
5. Differential regulation of α-adrenergic receptor subclasses by gonadal steroids in human myometrium
6. 2-adrenoceptors and 'imidazoline receptors
7. The imidazoline preferring receptor; Binding studies in bovine, rat and human brainstem
8. Selective increase of α(2A)-adrenoceptor agonist binding sites in brains of depressed suicide victims
9. The influence of estrogen on monoamine oxidase activity
10. Platelet heterogeneity; Relevance to the use of platelets to study psychiatric disorders
11. 2-adrenoceptors in the human central nervous system
12. Estrogen improves psychological function in asymptomatic postmenopausal women
13. Oestrogen and progesterone change the binding characteristics of α-adrenergic and serotonin receptors on rabbit platelets
14. Hamilton Depression Rating Scale. Extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia
15. Premenstrual changes; Patterns and correlates of daily ratings
16. A diagnostic interview; the schedule for affective disorders and schizophrenia
17. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla
18. 1-Imidazoline receptors; Definition, characterization, distribution and transmembrane signalling
19. 1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla
20. A novel mechanism of action for hypertension control; moxonidine as a selective I-1 imidazoline agonist
21. Optimization of radioligand binding assays for I-1 imidazoline sites
22. Imidazoline receptors and human brain disorders
23. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims
24. Role of estrogen in postmenopausal depression
25. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form
26. The multiple interactional biological processes that might lead to depression and gender differences in its appearance
27. 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes
28. The effect of estrogen replacement therapy on cognitive function in women; A critical review of the literature
29. Changes in MAO activity during estrogen treatment of females with endogenous depression
30. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists
31. Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein
32. 2 adrenergic receptor binding in human platelets; Alterations during the menstrual cycle
33. 2-adrenoceptors and imidazoline binding sites; Distribution of imidazoline binding sites in rat brain
34. Lack of effect of the α-adrenergic agonist clonidine on pulsatile luteinizing hormone secretion in a double blind study in men
35. Effects of estrogen therapy on plasma MAO activity and EEG driving responses of depressed women
36. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy
37. Agmatine; An endogenous clonidine-displacing substance in the brain
38. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC
39. Alpha-adrenoceptor changes after oestrogen treatment in platelets and other tissues in female rabbits
40. Sex differences in α-adrenergic receptors in the rat brain
41. Antihypertensive effect of a new imidazoline compound (clonidine) and chlorthalidone, individually and in combination
42. 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients
43. 1-imidazoline binding sites; Relationship with catecholamines in women of reproductive age
44. 2 adrenergic receptors
45. 2-adrenergic receptors; Implications for depression
46. 1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder
47. 3H-para-aminoclonidine binding in platelets of depressed patients
48. Platelet I-1 imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients
49. Nonadrenergic imidazoline binding sites on human platelets
50. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B
51. Localization of the imidazoline binding domain on monoamine oxidase B
52. Agmatine; An endogenous ligand at imidazoline receptors is a novel neurotransmitter
53. Estrogen treatment decreases α-adrenergic binding sites on rabbit pletelets
54. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
55. 2 adrenergic agonist clonidine
56. Research diagnostic criteria; Rationale and reliability
57. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
58. Adrenoceptor and imipramine receptor binding during the menstrual cycle
59. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat
60. 2 adrenoceptors and the menstrual cycle
61. 2-imidazoline binding sites on monoamine oxidases
62. 2 adrenoceptor binding and function during the menstrual cycle
63. Distinct α-noradrenergic receptors differentiated by binding and physiological relationships
64. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women [see comments]